In a recently published study based on the VA’s Million Veteran Program, men with the HOXB13 p.G84E variant had:
- Higher risk of prostate cancer
- Slightly earlier age at diagnosis
- Did not tend to develop more aggressive disease
Learn more at: https://jnccn.org/view/journals/jnccn/23/10/article-e257055.xml
Reference: Crawford et al. J Natl Compr Canc Netw. 2025;23(10):e257055. PMID: 40953603.